Table 4.

Complications following UAE and MRgHIFU treatments

#	Complications	UAE (# of complications/all patients, # of studies)	MRgHIFU (# of complications/all patients, %)	p value
1	Fever	19/736, 1 study	0/689	< 0.0001
2	Pain	123/736, 4 studies	168/689, 7 studies	0.0004
3	Transitory sciatic neuralgia	0/736	2/689, 2 studies	0.2336
4	Numbness	0/736	15/689, 2 studies	< 0.0001
5	Nausea, vomiting	56/736, 3 studies	7/689, 2 studies	< 0.0001
6	Anorexia	35/736, 2 studies	0/689	< 0.0001
7	Migraine	1/736, 1 study	0/689	1.0000
8	Fatigue	35/736, 2 studies	0/689	< 0.0001
9	Discharged myoma debris	2/736, 1 study	0/689	0.5002
10	Fibroid expulsion	13/736, 4 studies	0/689	0.0003
11	Oligomenorrhea	3/736,1 study	0/689	0.2503
12	Transient amenorrhea	17/736,4 studies	0/689	< 0.0001
13	Permanent amenorrhea	8/736, 3 studies	1/689, 1 study	0.0394
14	Bladder compression syndrome	3/736, 2 studies	1/689, 1 study	0.6253
15	Upper urine tract infection	1/736, 1 study	1/689,1 study	1.0000
16	Inguinal hematoma	9/736, 3 studies	0/689	0.0040
17	Bilateral pulmonary embolism	1/736, 1 study	0/689	1.0000
18	Abdominal distension	34/736, 2 studies	4/689, 1 study	< 0.0001
19	Skin lesion	0/736	61/689, 8 studies	< 0.0001
20	Pruritic rash related to the procedure	11/736, 2 studies	0/689	< 0.0010
21	infection of the necrotic fibroid	0/736	1/689, 1 study	0.4835